A top-5 pharma partnered with Medable on two pediatric vaccine studies in South Africa, where parents and guardians consent on behalf of their children. By reviewing consent materials from the caregiver’s perspective, Medable flagged inconsistencies early enough for the sponsor to revise the forms and secure IRB re-approval before first patient in.

‍

Learn how Medable is powering a decade-long, global long-term follow-up (LTFU) obesity study, achieving an impressive 97% patient retention rate without using a traditional EDC system all while delivering a compliant, scalable, and cost-efficient solution.

‍

It has become clear that our industry has reachedthe limits of human-only clinical development. As clinical trials have become increasingly complex, the endeavors that people alone can perform are no longer sufficient to generate the momentum needed to address the growing burden of human disease. This has led to longer drug development timelines and significant delays for patients. One large are of lost time is “white space,” definied simply as unproductive time caused by manual, sequential processes and fragmented data systems. Thankfully, a solution lies in agentic AI and its abilities to perform series of tasks.